These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 17371337

  • 1. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A.
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [Abstract] [Full Text] [Related]

  • 2. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
    Watanabe S, Okura T, Kurata M, Irita J, Manabe S, Miyoshi K, Fukuoka T, Murakami K, Higaki J.
    Clin Ther; 2006 Oct; 28(10):1677-85. PubMed ID: 17157123
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 4. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T, Iyisoy A, Kursaklioglu H, Kardesoglu E, Kilic S, Turhan H, Yilmaz MI, Ozcan O, Yaman H, Isik E, Fici F.
    J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 6. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppressive effects of valsartan on microalbuminuria and CRP in patients with metabolic syndrome (Val-Mets).
    Shishido T, Konta T, Nishiyama S, Miyashita T, Miyamoto T, Takasaki S, Nitobe J, Watanabe T, Takeishi Y, Kubota I.
    Clin Exp Hypertens; 2011 Sep; 33(2):117-23. PubMed ID: 21269062
    [Abstract] [Full Text] [Related]

  • 9. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
    Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O.
    J Hypertens; 2006 Nov; 24(11):2163-8. PubMed ID: 17053536
    [Abstract] [Full Text] [Related]

  • 10. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
    Tsai WC, Lin CC, Chen JY, Huang YY, Lee CH, Li WT, Weng CM, Chen JH.
    Blood Press; 2008 Nov; 17(4):233-8. PubMed ID: 18671144
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3.
    Hansel B, Girerd X, Bonnefont-Rousselot D, Bittar R, Chantepie S, Orsoni A, Bruckert E, Chapman MJ, Kontush A.
    Am J Cardiovasc Drugs; 2011 Oct 01; 11(5):317-25. PubMed ID: 21699274
    [Abstract] [Full Text] [Related]

  • 12. Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy.
    Cai J, Huang Z, Yang G, Cheng K, Ye Q, Ming Y, Zuo X, Zhou P, Yuan H.
    Am J Cardiovasc Drugs; 2011 Dec 01; 11(6):401-9. PubMed ID: 22149319
    [Abstract] [Full Text] [Related]

  • 13. Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome.
    Fogari R, Zoppi A, Mugellini A, Maffioli P, Lazzari P, Derosa G.
    Hypertens Res; 2011 Dec 01; 34(12):1321-6. PubMed ID: 21814211
    [Abstract] [Full Text] [Related]

  • 14. Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension.
    Ke YS, Tao YY, Yang H, Yu GH.
    Acta Pharmacol Sin; 2003 Apr 01; 24(4):337-41. PubMed ID: 12676074
    [Abstract] [Full Text] [Related]

  • 15. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
    Karotsis AK, Symeonidis A, Mastorantonakis SE, Stergiou GS, Home-Di-Plus Study Group.
    Clin Exp Hypertens; 2006 Oct 01; 28(7):655-62. PubMed ID: 17060064
    [Abstract] [Full Text] [Related]

  • 16. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients.
    Konrad T, Franke S, Schneider F, Bär F, Vetter G, Winkler K.
    J Hum Hypertens; 2011 Jan 01; 25(1):18-24. PubMed ID: 20237501
    [Abstract] [Full Text] [Related]

  • 17. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 01; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 18. Indapamide decreases plasma adiponectin concentration in patients with essential hypertension.
    Piecha G, Adamczak M, Chudek J, Wiecek A.
    Kidney Blood Press Res; 2007 Feb 01; 30(3):187-94. PubMed ID: 17536226
    [Abstract] [Full Text] [Related]

  • 19. Amlodipine improves endothelial function and metabolic parameters in patients with hypertension.
    Koh KK, Han SH, Ahn JY, Chung WJ, Lee Y, Shin EK.
    Int J Cardiol; 2009 Mar 20; 133(1):23-31. PubMed ID: 18199500
    [Abstract] [Full Text] [Related]

  • 20. Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
    Trenkwalder P, Schaetzl R, Borbas E, Handrock R, Klebs S.
    Blood Press Suppl; 2008 Dec 20; 2():13-21. PubMed ID: 19205092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.